期刊文献+

血浆置换治疗血栓性血小板减少性紫癜及影响因素研究 被引量:2

Plasma exchange treatment of thrombotic thrombocytopenic purpura and its influential factors
下载PDF
导出
摘要 目的探讨血浆置换(PE)治疗血栓性血小板减少性紫癜(TTP)临床疗效评价及影响因素的相关性研究。方法对12例TTP患者进行PE治疗,每例连续进行3次以上,每次置换60~80ml/kg,治疗期间同时运用免疫抑制剂。结果12例TTP患者中,2例死亡,1例转院,9例患者贫血纠正,出血症状好转,发热消退,血小板计数上升至正常水平,肾功能(肌肝、尿素氮)指标恢复正常,乳酸脱氢酶(LDH)下降至400U/L以下,6例痊愈出院,3例临床症状得到缓解和控制,有效率达75%。结论PE治疗对TTP患者疗效显著,禁忌输注血小板与冷沉淀。 Objective To study plasma exchange (PE) in the treatment of thrombotic thrombocytopenic purpura (TTP) , the clinical evaluation of the curative effect and the correlation of related factors. Methods 12 patients with TTP were treated with PE for more than three times. Replacement quantity was 60ml-80ml /Kg each time, simultaneously using immunosuppressive treatment. Results Of 12 patients with TTP, 2 cases died, 1 case was transferred, 9 cases had correction of anemia, improvement of bleeding symptoms, dissipation of fever, platelet count rose to normal levels, and renal function (creatinine, blood urea nitrogen) indexes returned to normal, lactate dehydrogenase LDH dropped to below 400, 6 cases were discharged, 3 cases had alleviation and control of clinical symptoms. The effective rate was 75%. Conclusion PE for the treatment of TTP has obvious effect. Platelet transfusion and cryoprecipitate are prohibited.
出处 《检验医学与临床》 CAS 2007年第7期597-598,共2页 Laboratory Medicine and Clinic
关键词 血浆置换 血栓性血小板减少性紫癜 影响因素 plasma exchange thrombotic thrombocytopenic purpura influence factor
  • 相关文献

参考文献6

二级参考文献11

  • 1Piero Ruggenenti Giuspeep Remuzzi.Thrombotic thrombocytopenic pripura and related disorders.Hematology/oncology Clinics of Northern America,1990,4(1):219
  • 2Soejima K,Mimura N,Hirashima M,et al.A novel human metalloprotease synthesized in the liver and secreted into blood: possibly, the von Willebrand factor-cleaving protease[].Journal of Biochemistry.2001
  • 3Tsai H,Lian EC.Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura[].The New England Journal of Medicine.1998
  • 4Fujikawa K,Suzuki H,McMullen B,et al.Purification of human von Wille-brand factor-cleaving protease and its identification as a new member of the metalloproteinase family[].Blood.2001
  • 5Levy GG,Nichols WC,Lian EC,et al.Mutation in a member of the ADAMTS gene family cause thrombotic thrombocypenic purpura[].Nature.2001
  • 6Gerritsen HE,Robles R,Lammle B,et al.Partial amino acid sequence of purified von Willebrand factor-cleaving protease[].Blood.2001
  • 7Allford SL,Harrison P,Lawarie AS,et al.von Willebrand factor-cleaving protease in congenital thrombotic thrombocytopenic purpura[].British Journal of Haematology.2000
  • 8Furlan M,Robles R.von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome[].The New England Journal of Medicine.1998
  • 9Zheng XL,Chung D,Takayama TK,et al.Structure of von Willebrand factor cleaving protease (ADAMTS13 ), a metalloprotease involved in thrombotic thrombocypenic purpura[].Journal of Biological Chemistry.2001
  • 10Tsai,Kaul D,Lee T.Infusion of von Willebrand factor (vWF)-cleaving metalloproteinase enhances vWF proteolysis in mice[].Blood.1999

共引文献20

同被引文献26

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部